Viruses cause type 1 diabetes in animals

Annals of the New York Academy of Sciences

Volumn 1079, Issue , 2006, Pages 138-146

  Yoon, Ji Won ^a   Jun, Hee Sook ^a  

^a The Chicago Medical College   (United States)

Author keywords

Cytokines; Encephalomyocarditis virus; Kilham rat virus; Macrophages; Pancreatic b cells; T cells; Type 1 diabetes

Indexed keywords

AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CONFERENCE PAPER; DIABETOGENESIS; DOWN REGULATION; ENCEPHALOMYOCARDITIS VIRUS; GENOMICS; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; NONHUMAN; PANCREAS ISLET BETA CELL; POINT MUTATION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VIRUS; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALIA; ENCEPHALOMYOCARDITIS VIRUS; KILHAM RAT VIRUS;

EID: 33845695056     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1375.021     Document Type: Conference Paper

References (27)

1. JUN, H.S. & J.W. YOON. 2003. A new look at viruses in type 1 diabetes. Diabetes Metab. Res. Rev. 19: 8-31.
2. CRAIGHEAD, J.E. & M.F. MCLANE. 1968. Diabetes mellitus: induction in mice by encephalomyocarditis virus. Science 162: 913-914.
3. GUBERSKI, D.L. et al. 1991. Induction of type I diabetes by Kilham's rat virus in diabetes-resistant BB/Wor rats. Science 254: 1010-1013.
4. ROSS, M.E. et al. 1976. Virus-induced diabetes mellitus. IV Genetic and environmental factors influencing the development of diabetes after infection with the M variant of encephalomyocarditis virus. Diabetes 25: 190-197.
5. YOON, J., T. ONODERA & A.L. NOTKINS. 1977. Virus-induced diabetes mellitus: VIII. Passage of encephalomyocarditis virus and severity of diabetes in susceptible and resistant strains of mice. J. Gen. Virol. 37: 225-232.
6. YOON, J.W. et al. 1980. Virus-induced diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of encephalomyocarditis virus. J. Exp. Med. 152: 878-892.
7. RAY, U.R. et al. 1983. Virus-induced diabetes mellitus. XXV. Difference in the RNA fingerprints of diabetogenic and non-diabetogenic variants of encephalomyocarditis virus. J. Gen. Virol. 64(Pt 4): 947-950.
8. BAE, Y.S., H.M. EUN & J.W. YOON. 1989. Genomic differences between the diabetogenic and nondiabetogenic variants of encephalomyocarditis virus. Virology 170: 282-287.
9. BAE, Y.S. & J.W. YOON. 1993. Determination of diabetogenicity attributable to a single amino acid, Ala776, on the polyprotein of encephalomyocarditis virus. Diabetes 42: 435-443.
10. JUN, H.S. et al. 1997. Gain or loss of diabetogenicity resulting from a single point mutation in recombinant encephalomyocarditis virus. J. Virol. 71: 9782-9785.
11. JUN, H.S. et al. 1998. Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein. Diabetes 47: 576-582.
12. ONODERA, T. et al. 1978. Evidence for a single locus controlling susceptibility to virus-induced diabetes mellitus. Nature 274: 693-696.
13. YOON, J.W. et al. 1985. Virus-induced diabetes mellitus. No evidence for immune mechanisms in the destruction of beta-cells by the D-variant of encephalomyocarditis virus. Diabetes 34: 922-925.
14. BAEK, H.S. & J.W. YOON. 1991. Direct involvement of macrophages in destruction of beta-cells leading to development of diabetes in virus-infected mice. Diabetes 40: 1586-1597.
15. BAEK, H.S. & J.W. YOON. 1990. Role of macrophages in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J. Virol. 64: 5708-5715.
16. JUN, H.S. & J.W. YOON. 2001. The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals. Diabetologia 44: 271-285.
17. HIRASAWA, K. et al. 1997. Possible role of macrophage-derived soluble mediators in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J. Virol. 71: 4024-4031.
18. KANETO, H. et al. 1995. Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes 44: 733-738.
19. HIRASAWA, K. et al. 1999. Prevention of encephalomyocarditis virus-induced diabetes in mice by inhibition of the tyrosine kinase signalling pathway and subsequent suppression of nitric oxide production in macrophages. J. Virol. 73: 8541-8548.
20. CHOI, K.S. et al. 2001. Role of Hck in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J. Virol. 75: 1949-1957.
21. ZIPRIS, D. et al. 2005. TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats. J. Immunol. 174: 131-142.
22. CHUNG, Y.H. et al. 1997. Role of macrophages and macrophage-derived cytokines in the pathogenesis of Kilham rat virus-induced autoimmune diabetes in diabetes-resistant BioBreeding rats. J. Immunol. 159: 466-471.
23. MENDEZ, I.I. et al. 2004. Immunoregulatory role of nitric oxide in Kilham rat virus-induced autoimmune diabetes in DR-BB rats. J. Immunol. 173: 1327-1335.
24. CHUNG, Y.H. et al. 2000. Cellular and molecular mechanism for Kilham rat virus-induced autoimmune diabetes in DR-BB rats. J. Immunol. 165: 2866-2876.
25. FOWELL, D. et al. 1991. Subsets of CD4+ T cells and their roles in the induction and prevention of autoimmunity. Immunol. Rev. 123: 37-64.
26. LIBLAU, R.S., S.M. SINGER & H.O. MCDEVITT. 1995. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16: 34-38.
27. + T cell populations. J. Immunol. 170: 3592-3602.